Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.840
-0.110 (-5.64%)
At close: May 29, 2026, 4:00 PM EDT
1.840
0.00 (0.00%)
After-hours: May 29, 2026, 5:28 PM EDT
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $27.41 million as of May 29, 2026. Its market cap has decreased by -52.90% in one year.
Market Cap
27.41M
Enterprise Value
7.70M
1-Year Change
-52.90%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $27.41M, a decrease of -78.09%. That is a compound annual growth rate of -50.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 29.05M | 42.41% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroSense Therapeutics | 30.82M |
| Polyrizon | 30.08M |
| Neuphoria Therapeutics | 29.52M |
| Lisata Therapeutics | 28.90M |
| Skye Bioscience | 28.88M |
| GridAI Technologies | 28.58M |
| Kyntra Bio | 28.40M |
| CervoMed | 28.24M |